Affinity Investment Advisors’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-25,209
| Closed | -$376K | – | 198 |
|
2021
Q4 | $376K | Sell |
25,209
-4,303
| -15% | -$64.2K | 0.15% | 147 |
|
2021
Q3 | $758K | Sell |
29,512
-245
| -0.8% | -$6.29K | 0.34% | 112 |
|
2021
Q2 | $776K | Buy |
29,757
+7,280
| +32% | +$190K | 0.35% | 108 |
|
2021
Q1 | $793K | Buy |
22,477
+149
| +0.7% | +$5.26K | 0.29% | 104 |
|
2020
Q4 | $564K | Buy |
22,328
+2,086
| +10% | +$52.7K | 0.23% | 114 |
|
2020
Q3 | $763K | Buy |
+20,242
| New | +$763K | 0.33% | 71 |
|